Orally-Administered Caspase Inhibitor PF-03491390 Is Retained in the Liver for Prolonged Periods With Low Systemic Exposure, Exerting a Hepatoprotective Effect Against α-Fas-Induced Liver Injury in a Mouse ModelYoshinobu Ueno, Hiroyuki Eda, Yukiko Moriguchi et al.|Journal of Pharmacological Sciences|2007Cited by 23
Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT4 receptorTohru Komada, Hiroyuki Eda, Tomomi Matsuura et al.|Pharmacological Research|2009Cited by 2